Evidence map›Paper›PMID 35225709›Full record

ArticleThe Journal of international medical research2022

Association of the methylenetetrahydrofolate reductase (

Lu-Wen Huang, Lin-Lin Li, Juan Li, Xiao-Rong Chen, Ming Yu

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lu-Wen HuangDepartment of Neurology, Suining Central Hospital, Suining, Sichuan Province, China.ORCID https://orcid.org/0000-0002-4258-4863
Lin-Lin LiDepartment of Neurology, Suining Central Hospital, Suining, Sichuan Province, China.
Juan LiDepartment of Neurology, Suining Central Hospital, Suining, Sichuan Province, China.
Xiao-Rong ChenDepartment of Neurology, Suining Central Hospital, Suining, Sichuan Province, China.
Ming YuDepartment of Neurology, Suining Central Hospital, Suining, Sichuan Province, China.
Suizhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine whether the methylenetetrahydrofolate reductase (

methodsThis case-control study recruited angiogram-diagnosed patients with ischaemic stroke and healthy control subjects. The plasma Hcy concentrations were measured and the

resultsThis study recruited 198 patients with ischaemic stroke and 168 controls. The TT genotype conferred a higher risk for ischaemic stroke than the CC genotype (odds ratio of 3.563; 95% confidence interval [CI] 1.412, 4.350). The T allele was the predisposing allele for ischaemic stroke. Hcy had an area under the receiver operating characteristic (ROC) curve of 0.624 (95% CI 0.530, 0.758). The ROC for Hcy demonstrated its usefulness in predicting ischaemic stroke. Hcy levels were not associated with ischaemic stroke severity as measured by the NIHSS.

conclusionThe

Indexed as

Brain IschemiaIschemic StrokeMethylenetetrahydrofolate Reductase (NADPH2)StrokeCase-Control StudiesGenetic Predisposition to DiseaseGenotypeHomocysteineHumansRisk FactorsHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanC677T mutationcase–control studyhomocysteineIschaemic strokeMTHFR gene polymorphisms

Identifiers

PMID35225709
PMCPMC8894968
OpenAlexW4214481241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.